Page 170 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 170
Liver Tumours: Experimental (Cont.)
YI P0289 EVOLUTION ANALYSIS BY DEEP SEQUENCING REVEALED
HIGH IMPACT OF THE MITOCHONDRIAL GENOME
IN HEPATOCELLULAR CARCINOMA INITIATION AND
PROGRESSION
Wafa Amer*, Alexander Quass, Uta Drebber, Hannah Eischeid,
Ulrike Koitzsch, Anne Arens, Claudia Vollbrecht, Reinhard Büttner,
Margarete Odenthal, Germany
YI P0290 PLACENTAL GROWTH FACTOR INHIBITION MODULATES
THE INTERPLAY BETWEEN HYPOXIA AND THE UNFOLDED
PROTEIN RESPONSE IN HEPATOCELLULAR CARCINOMA
Yves-Paul Vandewynckel*, Debby Laukens, Lindsey Devisscher,
Annelies Paridaens, Eliene Bogaerts, Xavier Verhelst, Anja Van den Bussche,
Sarah Raevens, Christophe Van Steenkiste, Bart Jonckx, Louis Libbrecht,
Anja Geerts, Peter Carmeliet, Hans Van Vlierberghe, Belgium
YI P0291 THE ONCOSTATIC ACTION OF SORAFENIB ON LIVER
CANCER CELLS IS CHANGED TO AN ONCOLYTIC EFFECT
ePOSTERS FOLLOWING PRE-TREATMENT WITH CHLOROQUINE:
DEMONSTRATION OF SYNERGY BETWEEN CHLOROQUINE
AND SORAFENIB AS A POTENTIAL NOVEL APPROACH TO
TREATMENT OF HCC
Francesco De Chiara*, Rosa Chiara Montella, Fausto Andreola,
Rajiv Jalan, The United Kingdom
YI P0292 KNOCKDOWN OF NANOG REVERSES THE
CHEMORESISTANCE TO DOXORUBICIN IN LIVER CANCER
STEM-LIKE CELLS BY REDUCING ABCB1 AND ABCG2
EXPRESSION
Jiajia Zhou*, Rufu Chen, Xiaogeng Deng, China
YI P0293 TARGETING GLUCOSYLCERAMIDE SYNTHASE INCREASES
SORAFENIB EFFICACY AND EVADES SORAFENIB
RESISTANCE IN HCC MODELS
Milica Stefanovic*, Anna Tutusaus, Cristina Barcena,
Guillermo A. Martinez-Nieto, Montserrat Marí, Carmen Garcia-Ruiz,
Jose C. Fernandez-Checa, Albert Morales, Spain
YI P0294 ONCOGENESIS: A POTENTIAL “OFF-TARGET” EFFECT OF
RAIOFREQUENCY ABLATION
Nir Rozenblum*, Evelyne Zeira, Viviana Scaiewicz, Baruch Bulvik,
Svetlana Gourevitch, Eithan Galun, Nahum S. Goldberg, Israel
170 The International Liver Congress™ 2015 • ILC Programme
YI P0289 EVOLUTION ANALYSIS BY DEEP SEQUENCING REVEALED
HIGH IMPACT OF THE MITOCHONDRIAL GENOME
IN HEPATOCELLULAR CARCINOMA INITIATION AND
PROGRESSION
Wafa Amer*, Alexander Quass, Uta Drebber, Hannah Eischeid,
Ulrike Koitzsch, Anne Arens, Claudia Vollbrecht, Reinhard Büttner,
Margarete Odenthal, Germany
YI P0290 PLACENTAL GROWTH FACTOR INHIBITION MODULATES
THE INTERPLAY BETWEEN HYPOXIA AND THE UNFOLDED
PROTEIN RESPONSE IN HEPATOCELLULAR CARCINOMA
Yves-Paul Vandewynckel*, Debby Laukens, Lindsey Devisscher,
Annelies Paridaens, Eliene Bogaerts, Xavier Verhelst, Anja Van den Bussche,
Sarah Raevens, Christophe Van Steenkiste, Bart Jonckx, Louis Libbrecht,
Anja Geerts, Peter Carmeliet, Hans Van Vlierberghe, Belgium
YI P0291 THE ONCOSTATIC ACTION OF SORAFENIB ON LIVER
CANCER CELLS IS CHANGED TO AN ONCOLYTIC EFFECT
ePOSTERS FOLLOWING PRE-TREATMENT WITH CHLOROQUINE:
DEMONSTRATION OF SYNERGY BETWEEN CHLOROQUINE
AND SORAFENIB AS A POTENTIAL NOVEL APPROACH TO
TREATMENT OF HCC
Francesco De Chiara*, Rosa Chiara Montella, Fausto Andreola,
Rajiv Jalan, The United Kingdom
YI P0292 KNOCKDOWN OF NANOG REVERSES THE
CHEMORESISTANCE TO DOXORUBICIN IN LIVER CANCER
STEM-LIKE CELLS BY REDUCING ABCB1 AND ABCG2
EXPRESSION
Jiajia Zhou*, Rufu Chen, Xiaogeng Deng, China
YI P0293 TARGETING GLUCOSYLCERAMIDE SYNTHASE INCREASES
SORAFENIB EFFICACY AND EVADES SORAFENIB
RESISTANCE IN HCC MODELS
Milica Stefanovic*, Anna Tutusaus, Cristina Barcena,
Guillermo A. Martinez-Nieto, Montserrat Marí, Carmen Garcia-Ruiz,
Jose C. Fernandez-Checa, Albert Morales, Spain
YI P0294 ONCOGENESIS: A POTENTIAL “OFF-TARGET” EFFECT OF
RAIOFREQUENCY ABLATION
Nir Rozenblum*, Evelyne Zeira, Viviana Scaiewicz, Baruch Bulvik,
Svetlana Gourevitch, Eithan Galun, Nahum S. Goldberg, Israel
170 The International Liver Congress™ 2015 • ILC Programme
